IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, Monday announced the appointment of Joshua Bleharski as chief financial officer.
Before joining IDEAYA, Bleharski was Managing Director and Global Co-Head of Biopharma at J.P. Morgan's Healthcare Investment Banking group for 17 years. IDEAYA expects Bleharski to fully transition into his new role by early May.
In the pre-market trading, IDEAYA Biosciences is 1.83% lesser at $22.58 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.